Neuroscience

Study shows drug lowers levels of biomarker linked to ALS

A new study finds that a decades-old drug used to treat malaria lowers levels of a biomarker linked to the inherited form of amyotrophic lateral sclerosis, also known as ALS and Lou Gehrig's Disease. The research, conducted ...

Neuroscience

Big hunt for small molecule to treat neurodegenerative diseases

Late last year, University of Arizona colleagues Daniela Zarnescu and May Khanna sped west on Interstate 8 bound for a brain-research conference in San Diego. Khanna is a biochemist who works with small molecules. Zarnescu ...

Medications

FDA approves first new drug for ALS in decades

(HealthDay)—The first new drug to treat amyotrophic lateral sclerosis (ALS) in more than 20 years has been approved by the U.S. Food and Drug Administration.

Neuroscience

DMM launches new special collection on neurodegeneration

A growing aging population means that age-dependent neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis are affecting increasing numbers of ...

page 33 from 40